Completely AI-generated Novel Antibody
At immunitoAI™ we discover novel Antibody Therapeutics with pre-defined drug properties, entirely using AI. The AI-platform is built to be capable of generating de novo antibody and antibody fragments against any epitope and does not depend upon a biological source, animal or human, for the lead molecule. The generated antibodies are screened for drug-properties at the in-silico (computational) stage and only those antibodies that are fit to be drugs are taken to the in-house biological lab for experimental validation.
Read more on our blog.
Join us in our journey of making Antibody Therapy the norm.
We have launched a new blog series. Read more to know about our unique approach towards AI-driven novel antibody generation.
Selected in Startup Battlefield 200 at TechCrunch Disrupt 2023. Read more in the news.
Dr. Aridni Shah (CEO) speaks about "computational biology approaches in medicine" at Sugar Rush with Science, an event by CCAMP, Bangalore. Read more in the press.
Dr. Aridni Shah(CEO), visited the Bio, 2022 Conference at San Diego. Read more in the news.
Dr. Axel Brockmann (Associate Professor at NCBS), inaugurated our Office Space in Bangalore in December, 2021. Read more in the news.
We raised our seed round led by pi Ventures. Entrepreneur First also participated in the round along with other angels. Read more in the press.
We incubated the biological lab at C-CAMP in June, 2021. Read more in the news.
Send us an Email:
Office: 2nd Floor, 879, NTI Layout, 2nd Phase, Rajeev Gandhi Nagar, Kodigehalli, Railway Parallel Road, Bengaluru, Karnataka, India 560097
Lab: Centre for Cellular and Molecular Platforms (C-CAMP), NCBS-TIFR, GKVK Post, Bellary Rd, Bengaluru, Karnataka, India 560065